About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 805405, 7 pages
http://dx.doi.org/10.1155/2010/805405
Research Article

Gelsolin Restores A 𝛽 -Induced Alterations in Choroid Plexus Epithelium

1Neuroscience Laboratory, Research Center, Hospital 12 de Octubre, Avenida de Córdoba, 28041 Madrid, Spain
2Neurodegenerative Diseases Biomedical Research Center (CIBERNED), Madrid, Spain
3Mitochondrial Diseases Laboratory, Research Center, Hospital 12 de Octubre, 28041 Madrid, Spain
4Rare Disorders Biomedical Research Center (CIBERER), Madrid, Spain

Received 30 June 2009; Accepted 19 January 2010

Academic Editor: Amanda McCann

Copyright © 2010 Teo Vargas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Selkoe, “The deposition of amyloid proteins in the aging mammalian brain: implications for Alzheimer's disease,” Annals of Medicine, vol. 21, no. 2, pp. 73–76, 1989. View at Scopus
  2. D. J. Selkoe, “Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid β-protein,” Annals of the New York Academy of Sciences, vol. 924, pp. 17–25, 2000. View at Scopus
  3. M. F. Knauer, B. Soreghan, D. Burdick, J. Kosmoski, and C. G. Glabe, “Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/β protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 16, pp. 7437–7441, 1992. View at Scopus
  4. C. Glabe, “Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease,” Journal of Molecular Neuroscience, vol. 17, no. 2, pp. 137–145, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. O. Dietrich, C. Spuch, D. Antequera, et al., “Megalin mediates the transport of leptin across the blood-CSF barrier,” Neurobiology of Aging, vol. 29, no. 6, pp. 902–912, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. R. N. Kalaria, “The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease,” Annals of the New York Academy of Sciences, vol. 893, pp. 113–125, 1999. View at Scopus
  7. T. Miyakawa, T. Kimura, S. Hirata, et al., “Role of blood vessels in producing pathological changes in the brain with Alzheimer's disease,” Annals of the New York Academy of Sciences, vol. 903, pp. 46–54, 2000. View at Scopus
  8. R. Deane and B. V. Zlokovic, “Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease,” Current Alzheimer Research, vol. 4, no. 2, pp. 191–197, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. F. J. Gonzalez-Velasquez, J. A. Kotarek, and M. A. Moss, “Soluble aggregates of the amyloid-β protein selectively stimulate permeability in human brain microvascular endothelial monolayers,” Journal of Neurochemistry, vol. 107, no. 2, pp. 466–477, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. S. Marco and S. D. Skaper, “Amyloid β-peptide1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells,” Neuroscience Letters, vol. 401, no. 3, pp. 219–224, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. T. Vargas, C. Ugalde, C. Spuch, et al., “Aβ accumulation in choroid plexus is associated with mitochondrial-induced apoptosis,” Neurobiology of Aging. 2008 Oct 4. [Epub ahead of print]. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. N. Matsumoto, H. Kitayama, M. Kitada, K. Kimura, M. Noda, and C. Ide, “Isolation of a set of genes expressed in the choroid plexus of the mouse using suppression subtractive hybridization,” Neuroscience, vol. 117, no. 2, pp. 405–415, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Q. Sun, M. Yamamoto, M. Mejillano, and H. L. Yin, “Gelsolin, a multifunctional actin regulatory protein,” The Journal of Biological Chemistry, vol. 274, no. 47, pp. 33179–33182, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. D. J. Kwiatkowski, T. P. Stossel, and S. H. Orkin, “Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain,” Nature, vol. 323, no. 6087, pp. 455–458, 1986. View at Scopus
  15. V. P. S. Chauhan, I. Ray, A. Chauhan, and H. M. Wisniewski, “Binding of gelsolin, a secretory protein, to amyloid β-protein,” Biochemical and Biophysical Research Communications, vol. 258, no. 2, pp. 241–246, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. I. Ray, A. Chauhan, J. Wegiel, and V. P. S. Chauhan, “Gelsolin inhibits the fibrillization of amyloid β-protein, and also defibrillizes its preformed fibrils,” Brain Research, vol. 853, no. 2, pp. 344–351, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Matsuoka, M. Saito, J. LaFrancois, et al., “Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to β-amyloid,” Journal of Neuroscience, vol. 23, no. 1, pp. 29–33, 2003. View at Scopus
  18. A. C. Hirko, E. M. Meyer, M. A. King, and J. A. Hughes, “Peripheral transgene expression of plasma gelsolin reduces amyloid in transgenic mouse models of Alzheimer's disease,” Molecular Therapy, vol. 15, no. 9, pp. 1623–1629, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. E. Carro, J. L. Trejo, T. Gomez-Isla, D. LeRoith, and I. Torres-Aleman, “Serum insulin-like growth factor I regulates brain amyloid-β levels,” Nature Medicine, vol. 8, no. 12, pp. 1390–1397, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. L. G. Nijtmans, N. S. Henderson, and I. J. Holt, “Blue Native electrophoresis to study mitochondrial and other protein complexes,” Methods, vol. 26, no. 4, pp. 327–334, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. T. P. Stossel, “Actin-membrane interactions in eukaryotic mammalian cells,” in Current Topis in Membranes and Transport, J. F. Hoffman and G. Giebisch, Eds., pp. 97–107, Academic Press, New York, NY, USA, 1990.
  22. L. Ji, A. Chauhan, and V. Chauhan, “Cytoplasmic gelsolin in pheochromocytoma-12 cells forms a complex with amyloid β-protein,” NeuroReport, vol. 19, no. 4, pp. 463–466, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. B. V. Zlokovic, C. L. Martel, E. Matsubara, et al., “Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid β at the blood-brain and blood-cerebrospinal fluid barriers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 9, pp. 4229–4234, 1996. View at Scopus
  24. E. Carro, C. Spuch, J. L. Trejo, D. Antequera, and I. Torres-Aleman, “Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I,” Journal of Neuroscience, vol. 25, no. 47, pp. 10884–10893, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. R. Deane, Z. Wu, A. Sagare, et al., “LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms,” Neuron, vol. 43, no. 3, pp. 333–344, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. S. M. Hammad, S. Ranganathan, E. Loukinova, W. O. Twal, and W. S. Argraves, “Interaction of apolipoprotein J-amyloid β-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid β-peptide,” The Journal of Biological Chemistry, vol. 272, no. 30, pp. 18644–18649, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. C. V. Zerbinatti, D. F. Wozniak, J. Cirrito, et al., “Increased soluble amyloid-β peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 4, pp. 1075–1080, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. E. I. Christensen and H. Birn, “Megalin and cubilin: multifunctional endocytic receptors,” Nature Reviews Molecular Cell Biology, vol. 3, no. 4, pp. 256–266, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Ohtake, T. Maeno, H. Ueda, M. Ogihara, H. Natsume, and Y. Morimoto, “Poly-L-arginine enhances paracellular permeability via serine/threonine phosphorylation of ZO-1 and tyrosine dephosphorylation of occludin in rabbit nasal epithelium,” Pharmaceutical Research, vol. 20, no. 11, pp. 1838–1845, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. N. T. Collins, P. M. Cummins, O. C. Colgan, et al., “Cyclic strain-mediated regulation of vascular endothelial occludin and ZO-1: influence on intercellular tight junction assembly and function,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 1, pp. 62–68, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. H. Rincon-Choles, T. L. Vasylyeva, P. E. Pergola, et al., “ZO-1 expression and phosphorylation in diabetic nephropathy,” Diabetes, vol. 55, no. 4, pp. 894–900, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. P. H. Gibson and B. E. Tomlinson, “Numbers of Hirano bodies in the hippocampus of normal and demented people with Alzheimer's disease,” Journal of the Neurological Sciences, vol. 33, no. 1-2, pp. 199–206, 1977. View at Scopus
  33. A. Mendoza-Naranjo, C. Gonzalez-Billault, and R. B. Maccioni, “Aβ1-42 stimulates actin polymerization in hippocampal neurons through Rac1 and Cdc42 Rho GTPases,” Journal of Cell Science, vol. 120, no. 2, pp. 279–288, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. T. Müller, C. G. Concannon, M. W. Ward, et al., “Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD),” Molecular Biology of the Cell, vol. 18, no. 1, pp. 201–210, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. J.-M. Lee, K.-J. Yin, I. Hsin, et al., “Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy,” Annals of Neurology, vol. 54, no. 3, pp. 379–382, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. A. A. Talamagas, S. Efthimiopoulos, E. C. Tsilibary, M. E. Figueiredo-Pereira, and A. K. Tzinia, “Aβ(1–40)-induced secretion of matrix metalloproteinase-9 results in sAPPα release by association with cell surface APP,” Neurobiology of Disease, vol. 28, no. 3, pp. 304–315, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. G. Candiano, M. Bruschi, N. Pedemonte, et al., “Gelsolin secretion in interleukin-4-treated bronchial epithelia and in asthmatic airways,” American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 9, pp. 1090–1096, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. C. Harms, J. Bösel, M. Lautenschlager, et al., “Neuronal gelsolin prevents apoptosis by enhancing actin depolymerization,” Molecular and Cellular Neuroscience, vol. 25, no. 1, pp. 69–82, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. M. Endres, K. Fink, J. Zhu, et al., “Neuroprotective effects of gelsolin during murine stroke,” Journal of Clinical Investigation, vol. 103, no. 3, pp. 347–354, 1999. View at Scopus
  40. K. Furukawa, W. Fu, Y. Li, W. Witke, D. J. Kwiatkowski, and M. P. Mattson, “The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons,” Journal of Neuroscience, vol. 17, no. 21, pp. 8178–8186, 1997. View at Scopus
  41. R. C. Koya, H. Fujita, S. Shimizu, et al., “Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release,” The Journal of Biological Chemistry, vol. 275, no. 20, pp. 15343–15349, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Qiao, R. C. Koya, K. Nakagawa, et al., “Inhibition of Alzheimer's amyloid-β peptide-induced reduction of mitochondrial membrane potential and neurotoxicity by gelsolin,” Neurobiology of Aging, vol. 26, no. 6, pp. 849–855, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. A. Kulakowska, W. Drozdowski, A. Sadzynski, R. Bucki, and P. A. Janmey, “Gelsolin concentration in cerebrospinal fluid from patients with multiple sclerosis and other neurological disorders,” European Journal of Neurology, vol. 15, no. 6, pp. 584–588, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus